143 related articles for article (PubMed ID: 25069820)
1. Validation of an LC-MS/MS method for the determination of zopiclone, N-desmethylzopiclone and 2-amino-5-chloropyridine in whole blood and its application to estimate the original zopiclone concentration in stored specimens.
Nilsson GH; Kugelberg FC; Ahlner J; Kronstrand R
Int J Legal Med; 2015 Mar; 129(2):269-77. PubMed ID: 25069820
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of zopiclone, N-desmethylzopiclone, zopiclone N-oxide and 2-amino-5-chloropyridine in urine using LC-MS-MS.
Nilsson GH; Kugelberg FC; Ahlner J; Kronstrand R
J Anal Toxicol; 2014; 38(6):327-34. PubMed ID: 24790062
[TBL] [Abstract][Full Text] [Related]
3. Degradation of zopiclone during storage of spiked and authentic whole blood and matching dried blood spots.
Jantos R; Vermeeren A; Sabljic D; Ramaekers JG; Skopp G
Int J Legal Med; 2013 Jan; 127(1):69-76. PubMed ID: 22532152
[TBL] [Abstract][Full Text] [Related]
4. Stability tests of zopiclone in whole blood.
Nilsson GH; Kugelberg FC; Kronstrand R; Ahlner J
Forensic Sci Int; 2010 Jul; 200(1-3):130-5. PubMed ID: 20434282
[TBL] [Abstract][Full Text] [Related]
5. Quantitative determination of zopiclone and zolpidem in whole blood by liquid-liquid extraction and UHPLC-MS/MS.
Eliassen E; Kristoffersen L
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 971():72-80. PubMed ID: 25264915
[TBL] [Abstract][Full Text] [Related]
6. First derivative spectrofluorimetric determination of zopiclone and its degradation product, 2-amino-5-chloropyridine, in pharmaceutical formulations with preliminary tool in biological fluids for clinical evidence of zopiclone intake.
Al-Attas AS; Nasr JJ; Shalan S; Belal F
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Jun; 181():148-152. PubMed ID: 28359903
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel tandem mass spectrometry method for the quantification of eszopiclone without interference from 2-amino-5-chloropyridine and application in a pharmacokinetic study of rat.
Liu R; Liu D; Zhang J; Zang H; Gao Y
J Pharm Biomed Anal; 2020 Sep; 188():113363. PubMed ID: 32502953
[TBL] [Abstract][Full Text] [Related]
8. Influence of pre-analytical conditions on the interpretation of zopiclone concentrations in whole blood.
Nilsson GH; Kugelberg FC; Ahlner J; Kronstrand R
Forensic Sci Int; 2011 Apr; 207(1-3):35-9. PubMed ID: 20851542
[TBL] [Abstract][Full Text] [Related]
9. Rapid enantiomeric analysis of zopiclone in serum by supercritical fluid chromatography-tandem mass spectrometry.
Segawa H; Iwata YT; Okada Y; Yamamuro T; Kuwayama K; Tsujikawa K; Kanamori T
J Forensic Sci; 2023 Jul; 68(4):1352-1358. PubMed ID: 37198996
[TBL] [Abstract][Full Text] [Related]
10. Distribution of zopiclone and main metabolites in hair following a single dose.
Hansen SL; Johansen SS; Nielsen MKK; Nilsson G; Kronstrand R
Forensic Sci Int; 2020 Jan; 306():110074. PubMed ID: 31809905
[TBL] [Abstract][Full Text] [Related]
11. Concentrations of zolpidem and zopiclone in venous blood samples from impaired drivers compared with femoral blood from forensic autopsies.
Jones AW; Holmgren A
Forensic Sci Int; 2012 Oct; 222(1-3):118-23. PubMed ID: 22673707
[TBL] [Abstract][Full Text] [Related]
12. [Progress on Determination and Analysis of Zopiclone in Biological Samples].
Shu CX; Gong D; Zhang LP; Zhao JX
Fa Yi Xue Za Zhi; 2017 Dec; 33(6):635-639. PubMed ID: 29441774
[TBL] [Abstract][Full Text] [Related]
13. HPLC-ESI-MS/MS validated method for simultaneous quantification of zopiclone and its metabolites, N-desmethyl zopiclone and zopiclone-N-oxide in human plasma.
Mistri HN; Jangid AG; Pudage A; Shrivastav P
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Mar; 864(1-2):137-48. PubMed ID: 18313371
[TBL] [Abstract][Full Text] [Related]
14. Comparison of zopiclone concentrations in oral fluid sampled with Intercept(®) oral specimen collection device and Statsure Saliva Sampler™ and concentrations in blood.
Gjerde H; Øiestad EL; Øiestad ÅM; Langødegård M; Gustavsen I; Hjelmeland K; Bernard JP; Christophersen AS
J Anal Toxicol; 2010 Nov; 34(9):590-3. PubMed ID: 21073813
[TBL] [Abstract][Full Text] [Related]
15. A method for the rapid detection of the zopiclone degradation product 2-amino-5-chloropyridine.
Galloway JH; Marsh ID; Newton CM; Forrest AR
Sci Justice; 1999; 39(4):253-6. PubMed ID: 10795415
[TBL] [Abstract][Full Text] [Related]
16. Enantioselective analysis of zopiclone and its metabolites in plasma by liquid chromatography/tandem mass spectrometry.
Tonon MA; Jabor VA; Bonato PS
Anal Bioanal Chem; 2011 Jul; 400(10):3517-25. PubMed ID: 21547427
[TBL] [Abstract][Full Text] [Related]
17. UHPLC-MS/MS and UHPLC-HRMS identification of zolpidem and zopiclone main urinary metabolites and method development for their toxicological determination.
Strano Rossi S; Anzillotti L; Castrignanò E; Frison G; Zancanaro F; Chiarotti M
Drug Test Anal; 2014 Mar; 6(3):226-33. PubMed ID: 23512850
[TBL] [Abstract][Full Text] [Related]
18. Sensitive UPLC-MS-MS assay for 21 benzodiazepine drugs and metabolites, zolpidem and zopiclone in serum or plasma.
Marin SJ; Roberts M; Wood M; McMillin GA
J Anal Toxicol; 2012 Sep; 36(7):472-6. PubMed ID: 22833647
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective binding of zopiclone to human plasma proteins.
Fernandez C; Gimenez F; Thuillier A; Farinotti R
Chirality; 1999; 11(2):129-32. PubMed ID: 9951403
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of zopiclone and desmethylzopiclone in human plasma by high-performance liquid chromatography using fluorescence detection.
Nirogi RV; Kandikere VN; Mudigonda K
Biomed Chromatogr; 2006 Aug; 20(8):794-9. PubMed ID: 16292747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
